Prevalence of Keratoconus in Inflammatory Bowel Diseases
- Conditions
- Inflammatory Bowel DiseasesKeratoconus
- Interventions
- Device: Opthalmologic measure with DM OPD scan III (Nidek)
- Registration Number
- NCT02861339
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
A retrospective study has shown the association between the inflammatory bowel diseases (IBD) and the presence of a keratoconus. This new study will measure the prevalence of keratoconus and follow its activity in patients affected by IBD and followed up in hepatology-gastroenterology department at Nancy Hospital. The prevalence of keratoconus will be compared to known data of literature about general population.
The secondary purpose is to search for a relationship between the presence of a keratoconus and activity criteria of IBD.
Perspectives are a systematic screening for keratoconus in patients affected by IBD with the amelioration of the ophthalmologic care of IBD patients and confirmation of the recent hypothesis of inflammatory origin of keratoconus.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 201
- Informed consent
- Affiliation to social security plan
- Diagnosis of IBD since more than 3 years, under treatment or not
- Protected person
- Pregnant or breastfeeding women
- Person in life-and-death emergency
- Person deprived of liberty
- Refusal to remove contact lenses, where necessary
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Keratoconus and IBD Opthalmologic measure with DM OPD scan III (Nidek) Opthalmologic measure with DM OPD scan III (Nidek)
- Primary Outcome Measures
Name Time Method Absence or presence of keratoconus in IBD patients day 0 Data from OPD scan III corneal analyzer according to Rabinowitz and Klyce Maeda criteria. The presence of a keratoconus in at least one eye is considered positive.
- Secondary Outcome Measures
Name Time Method IBD clinical features using the Montreal classification for IBD day 0